miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer

miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer

Despite that androgen-deprivation therapy results in long-lasting responses, the disease inevitably progresses to metastatic castration-resistant prostate cancer. In this study, we identified miR-33b-3p as a tumor suppressor in prostate cancer. miR-33b-3p was significantly reduced in prostate cancer...

Full description

Bibliographic Details
Main Authors: Yu Mei, Kai Li, Zhicheng Zhang, Mengmeng Li, Hong Yang, Hui Wang, Xuemei Huang, Xinyuan Li, Shuhua Shi, Huanjie Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
miR-33b-3p
DOCK4
metastasis
prostate cancer
proteasome inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.740452/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.740452/full

Similar Items